Secured Research | Equipment Finance Originator | Monitor | Monitor Suite | Converge | STRIPES Leadership
No Result
View All Result
ABF Journal
Forward for Specialty Finance
SUBSCRIBE
Lender & Services Directory
  • News
    • People
    • Economy
    • All News
  • Deals
  • Magazine
    • Magazine Issues
    • Nominations
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Events
  • Recruiting
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Advertise
  • Contact Us
  • News
    • People
    • Economy
    • All News
  • Deals
  • Magazine
    • Magazine Issues
    • Nominations
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Events
  • Recruiting
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Advertise
  • Contact Us
No Result
View All Result
ABF Journal
No Result
View All Result
Home Deal Announcements

Akebia Enters into Term Loan Facility with Symbiotic Capital Worth Up to $140MM

The loan facility consists of an initial tranche of $60 million that was fully funded at closing and the ability to request up to an additional $80 million, which Symbiotic Capital may fund at its discretion.

byBrianna Wilson
November 16, 2026
in Deal Announcements, News

Akebia Therapeutics, a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, entered into a senior secured term loan facility with Symbiotic Capital. The loan facility consists of an initial tranche of $60 million that was fully funded at closing and the ability to request up to an additional $80 million, which Symbiotic Capital may fund at its discretion.

The Symbiotic loan facility closed on Nov. 12, 2026. Akebia used the proceeds from the initial tranche to repay in full its $55 million loan facility with BlackRock. The loan facility has a 60-month maturity, a 60-month interest-only period with principal due at maturity and bears interest at a variable monthly interest rate equal to the greater of WSJ Prime plus 4.5% or 11.5%.

“We are very pleased to announce this financing which enhances our operational flexibility and gives us the potential to access additional non-dilutive capital to advance our strategic initiatives. Today, we also reaffirm our cash runway guidance of at least two years,” Erik Ostrowski, Akebia’s chief financial and chief business officer, said. “We are excited to partner with Symbiotic Capital, whose deep expertise in healthcare financing makes them an ideal collaborator. We are also very appreciative of our partnership with BlackRock over the past several years.”

Chris York, senior managing director at Symbiotic Capital, added, “Akebia has a portfolio of revenue-generating products and a pipeline focused on kidney disease, led by a management team with deep experience in the space. We are pleased to provide this financing and look forward to supporting Akebia as it executes on its business strategy.”

Previous Post

VulcanForms Secures $500MM to Build Three New Factories

Related Posts

Advanced Power Closes $100M Corporate Credit Facility
News

VulcanForms Secures $500MM to Build Three New Factories

November 16, 2026
News

Nomura & Aventus Launch Misura Securitized Products, Private Credit Venture

November 16, 2026
News

Pinnacle Bank Promotes Dennett to President, CEO

November 16, 2026
Deal Announcements

SouthStar Capital Provides $750K Accounts Receivable Facility to Utah Landscaping Contractor

November 16, 2026
Deal Announcements

Monroe Capital Supports OceanSound Partners’ Investment in IMSAR

November 16, 2026
News

First Horizon Bank Names Finkle Palm Beach and Broward County Market President

November 16, 2026

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About Us

For over 50 years, RAM Holdings’ brands have led the commercial finance industry in publishing, talent development, research and events. ABF Journal’s audience is comprised of as many as 18,000 specialty finance industry executives, private equity investors, investment bankers, advisors, service providers and more.

Our Brands

  • Secured Research
  • Equipment Finance Originator
  • Monitor
  • Monitor Suite
  • Converge
  • STRIPES Leadership

 

Learn More

  • Advertise
  • Magazine
  • Contact Us

Newsletter

Driving specialty finance forward for decades with insights, recognition and deals. Sign up now.

SUBSCRIBE >>

© 2025 RAM Group Holdings - A Leading Commercial Finance Publishing Group For Over 50 Years

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • News
    • People
    • Economy
    • All News
  • Deals
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Magazine
    • Magazine Issues
    • Nominations
  • Molloy Associates
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Events
  • Advertise
  • Contact Us
Provider Directory >>

© 2025 RAM Group Holdings - A Leading Commercial Finance Publishing Group For Over 50 Years